The Next Generation in Opioid Science and Pain Relief - Opioid 4.0
CEO Kirkpatrick: “NextGen will see innovation in pain relief where the chemistry in the drug itself will restrict abuse, like Ensysce's novel prodrug, PF614. Ensysce Biosciences, Inc. (NASDAQ:ENSC) LA JOLLA, CA, USA, March 14, 2022 /EINPresswire.com …